Medicus Pharma Ltd. Common Stock
Price Action
Technical Summary
WEAKENINGMedicus Pharma Ltd. Common Stock is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 18), showing significant lag compared to the market leaders. Earnings growth of 48% provides fundamental context to the price action. However, price is extended 36% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.37 | +22.39% | ABOVE |
| 50 SMA | $0.34 | +36.43% | ABOVE |
| 100 SMA | $0.55 | -17.31% | BELOW |
| 150 SMA | $0.92 | -50.35% | BELOW |
| 200 SMA | $1.30 | -64.65% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MDCX in an uptrend right now?
MDCX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is MDCX overbought or oversold?
MDCX's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is MDCX outperforming the market?
MDCX has a Relative Strength (RS) Rating of 18 out of 99. MDCX is currently lagging the broader market.
Where is MDCX in its 52-week range?
MDCX is trading at $0.46, which is 12% of its 52-week high ($3.69) and 6% above its 52-week low ($0.26).
How volatile is MDCX?
MDCX has a Beta of 1.79 and 52-week volatility of 127%. It's more volatile than the S&P 500 - expect bigger swings.